Ophthalmology · Coral Gables, FL
NPI
1174215701
Since 2023
Specialty
Ophthalmology
Code 207W00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
1097 S Le Jeune Rd
Coral Gables, FL, 33134
Phone (305) 442-2020
Groups this clinician bills Medicare through
Medicare paid, 2024
$41K
455 services
Medicare patients, 2024
59
Average age 77
Drug cost, 2024
$2.2M
2,838 prescriptions
Company payments, 2025
$903
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ahad Deen was code 92014 (ophthalmological e&m), 98 times for 48 patients. In total Ahad Deen billed 455 services in 18 codes, and Medicare paid $41K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-06-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 98 | 48 | $94.09 | $9,221 |
| 92134 Computerized Ophthalmic Imaging | Office | 92 | 46 | $30.51 | $2,807 |
| 67028 Intravitreal Injection | Office | 52 | 25 | $90.72 | $4,717 |
| J7999 Compounded drug, not otherwise classified | Office | 39 | 20 | $66.64 | $2,599 |
By year: 2023 $32K for 254 services; 2024 $41K for 455 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ahad Deen prescribed most often to Medicare patients was Eylea (Aflibercept), with 531 prescriptions and refills. In total Ahad Deen wrote 2,838 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eylea Aflibercept | 531 | 610 | 173 | $1.3M |
| Latanoprost Generic | 329 | 478 | 108 | $1,547 |
| Prednisolone Acetate Generic | 215 | 263 | 109 | $5,634 |
| Brimonidine Tartrate Generic | 213 | 296 | 81 | $2,909 |
| Bromfenac Sodium Generic | 194 | 217 | 73 | $16K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 137 | 244 | 52 | $1,887 |
| Lumigan Bimatoprost | 131 | 180 | 52 | $48K |
| Ilevro Nepafenac | 117 | 170 | 59 | $43K |
| Eylea Hd Aflibercept | 117 | 130 | 42 | $398K |
| Moxifloxacin Moxifloxacin Hcl | 95 | 95 | 59 | $2,894 |
| Combigan Brimonidine Tartrate/Timolol | 76 | 114 | 29 | $26K |
| Dorzolamide Hcl Generic | 71 | 128 | 31 | $939 |
| Rhopressa Netarsudil Mesylate | 57 | 71 | 25 | $21K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 56 | 80 | 21 | $6,001 |
| Vabysmo Faricimab-Svoa | 54 | 63 | 18 | $141K |
Brand drugs: 1,754 claims; generic drugs: 1,084 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ahad Deen $903 ($903 in general payments such as food, travel and fees) from 8 companies. The largest payer was Abbvie Inc. with $278.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 11 | $278 |
| Mallinckrodt Hospital Products Inc. | 6 | $253 |
| Regeneron Healthcare Solutions, Inc. REGN | 8 | $141 |
| Alcon Vision LLC ALC | 4 | $92.95 |
| Genentech USA, Inc. ROG.SW | 2 | $57.57 |
| Astellas Pharma US Inc 4503.T | 1 | $33.18 |
| Apellis Pharmaceuticals, Inc. APLS | 1 | $27.9 |
| Bausch & Lomb Americas Inc. BLCO | 1 | $20.06 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.